Free Trial

Simplify Propel Opportunities ETF Rating

$15.24 -0.03 (-0.16%)
As of 09:35 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Simplify Propel Opportunities ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

SURI Aggregate Rating

Moderate Buy
2.61

Holdings in SURI have an aggregate rating of Moderate Buy based on 75 analyst ratings issued in the past year covering 13 companies (92.5% of the portfolio).

SURI Aggregate Price Target

$15.33
-0.94% Downside
High Prediction$15.33
Average Prediction$15.33
Low Prediction$15.33

Holdings in SURI have an aggregate price target of $15.33 and a range of $15.33 to $15.33 covering 13 companies (92.5% of the portfolio).

SURI Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
7 Buy rating(s)
Moderate Buy
2 Moderate Buy rating(s)
Hold
3 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Simplify Propel Opportunities ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 13 SURI Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
37.57%
Plains GP Holdings, L.P. stock logo
PAGP
Plains GP
$19.03
-1.3%
2.1754 of 5 stars
2.25$20.88 9.7%8Positive News
13.79%
Pathward Financial, Inc. stock logo
CASH
Pathward Financial
$73.24
-0.8%
4.1512 of 5 stars
2.50$91.00 24.3%2Positive News
11.20%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$50.60
-4.2%
4.0238 of 5 stars
3.00$81.57 61.2%8News Coverage
Earnings Report
Insider Trade
7.15%
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
$9.64
+2.5%
3.1166 of 5 stars
3.00$17.50 81.6%6News Coverage
Gap Up
4.78%
Abeona Therapeutics Inc. stock logo
ABEO
Abeona Therapeutics
$6.25
-0.4%
3.8846 of 5 stars
3.00$19.25 208.1%5Upcoming Earnings
4.10%
Achieve Life Sciences, Inc. stock logo
ACHV
Achieve Life Sciences
$2.58
-2.5%
1.9622 of 5 stars
3.50$14.33 456.6%4News Coverage
Earnings Report
2.83%
TScan Therapeutics, Inc. stock logo
TCRX
TScan Therapeutics
$1.68
-2.9%
3.7017 of 5 stars
3.00$7.80 364.6%5Upcoming Earnings
2.77%
Applied Therapeutics Inc. stock logo
APLT
Applied Therapeutics
$0.45
+3.2%
4.0907 of 5 stars
2.50$6.10 1,264.7%6
2.75%
Zevra Therapeutics, Inc. stock logo
ZVRA
Zevra Therapeutics
$11.85
-2.3%
2.071 of 5 stars
3.11$23.71 100.1%9Upcoming Earnings
Gap Up
2.30%
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
$1.52
+0.6%
2.0396 of 5 stars
2.40$7.00 360.8%5Upcoming Earnings
1.80%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$10.25
+0.5%
3.0541 of 5 stars
3.00$24.50 139.1%4News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
Gap Up
0.97%
Athira Pharma, Inc. stock logo
ATHA
Athira Pharma
$0.39
+5.7%
3.2725 of 5 stars
2.00$11.25 2,777.2%4News Coverage
Earnings Report
0.46%
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$8.30
+2.9%
3.5875 of 5 stars
3.11$22.56 171.7%9

This page (NYSEARCA:SURI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners